U.S. Markets open in 4 hrs 49 mins
  • S&P Futures

    4,062.25
    -13.25 (-0.33%)
     
  • Dow Futures

    34,359.00
    -100.00 (-0.29%)
     
  • Nasdaq Futures

    11,984.25
    -26.00 (-0.22%)
     
  • Russell 2000 Futures

    1,888.90
    -5.50 (-0.29%)
     
  • Crude Oil

    81.30
    +1.32 (+1.65%)
     
  • Gold

    1,810.50
    +0.90 (+0.05%)
     
  • Silver

    23.24
    -0.01 (-0.04%)
     
  • EUR/USD

    1.0557
    +0.0027 (+0.2534%)
     
  • 10-Yr Bond

    3.5060
    0.0000 (0.00%)
     
  • Vix

    20.27
    +0.43 (+2.17%)
     
  • GBP/USD

    1.2274
    -0.0022 (-0.1804%)
     
  • USD/JPY

    135.3260
    +1.0550 (+0.7857%)
     
  • BTC-USD

    17,321.06
    +292.54 (+1.72%)
     
  • CMC Crypto 200

    410.73
    +9.30 (+2.32%)
     
  • FTSE 100

    7,561.86
    +5.63 (+0.07%)
     
  • Nikkei 225

    27,820.40
    +42.50 (+0.15%)
     

Zacks.com featured highlights Medpace, Texas Pacific Land and Delek

For Immediate Release

Chicago, IL – July 20, 2022 – Stocks in this week’s article are Medpace MEDP, Texas Pacific Land TPL and Delek US Holdings DK.

3 Top Stocks to Bet On for Superb Earnings Growth

One of the most important variables influencing the share price of a company is earnings growth. After all, earnings growth is the highest priority for the top brass of any organization. This is because if the company doesn't make money, it won't last over the long haul.

Study a company's revenues over a given period, subtract the cost of production, and you have earnings. But, expectations of earnings also play a significant role.

Earnings Estimates & Share Price Movements

Often, we have seen a decline in the stock price despite earnings growth and a rally in price following an earnings decline. This is largely the result of a company's earnings failing to meet market expectations.

Earnings estimates embody analysts' opinion on factors such as sales growth, product demand, competitive industry environment, profit margins and cost control. Thus, earnings estimates serve as a valuable tool, while making investment decisions. Earnings estimates also help analysts assess the cash flow to determine the fair value of a firm.

Investors, thus, should be on the lookout for stocks that are ready to make a big move. Hence, it is important for investors to buy stocks that have historical earnings growth and are seeing a rise in quarterly and annual earnings estimates.

The above criteria narrowed down the universe of around 7,839 stocks to only 28. Here are the top three stocks that stand out:

Medpace is a scientifically-driven, global, full-service clinical contract research organization. Medpace currently has a Zacks Rank #2 (Buy). MEDP's expected earnings growth rate for the current year is 22.7%.

Texas Pacific Land generates revenues from pipeline, power line and utility easements, commercial leases, material sales and seismic and temporary permits related to land uses, including midstream infrastructure projects and hydrocarbon processing facilities. Texas Pacific Land currently has a Zacks Rank #1 (Strong Buy). TPL's expected earnings growth rate for the current year is 74.4%. You can see the complete list of today's Zacks #1 Rank stocks here.

Delek US Holdings is an independent refiner, transporter and marketer of petroleum products. Delek US Holdings Land currently has a Zacks Rank #1. DK's expected earnings growth rate for the current year is nearly 302%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1952179/3-top-stocks-to-bet-on-for-superb-earnings-growth

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Delek US Holdings, Inc. (DK) : Free Stock Analysis Report
 
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
 
Texas Pacific Land Corporation (TPL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research